{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:40:20Z","timestamp":1777340420126,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ejogrb.2003.11.027","type":"journal-article","created":{"date-parts":[[2004,7,7]],"date-time":"2004-07-07T20:34:31Z","timestamp":1089232471000},"page":"125-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Insulin resistance and metformin in polycystic ovary syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Avi","family":"Ben-Haroush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yariv","family":"Yogev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2003.11.027_BIB1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Metab. Clin. N. Am."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocrinol. Rev."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB6","first-page":"1241","article-title":"Defects in beta-cell function in functional ovarian hyperandrogenism","volume":"76","author":"O\u2019Meara","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB7","first-page":"577","article-title":"Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism","volume":"62","author":"Barbieri","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humrep\/10.1.75","article-title":"Metabolic regulation of androgen production by human thecal cells in vitro","volume":"10","author":"Nahum","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB14","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/humrep\/15.1.86","article-title":"Clinical presentation of PCOS following development of an insulinoma: case report","volume":"15","author":"Murray","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/jcem-66-2-266","article-title":"Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein","volume":"66","author":"Suikkari","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jcem-68-1-135","article-title":"Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin","volume":"68","author":"Suikkari","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome","volume":"72","author":"La Marca","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0960-0760(95)00108-C","article-title":"Sex hormone-binding globulin and female reproductive function","volume":"53","author":"Botwood","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0015-0282(16)49211-3","article-title":"Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion","volume":"45","author":"Geffner","year":"1986","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenemic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0015-0282(16)57412-3","article-title":"A twin study of polycystic ovary syndrome","volume":"63","author":"Jahanfar","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1067\/mob.2000.107627","article-title":"Induction of ovulation in infertile women with hyperandrogenism and insulin resistance","volume":"183","author":"Barbieri","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB28","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. In: Consensus Development Conference on Insulin Resistance; Diab. Care 1998;21:310\u201314.","DOI":"10.2337\/diacare.21.2.310"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB29","first-page":"2694","article-title":"A fasting glucose-to-insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB30","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/humrep\/17.8.1950","article-title":"Should patients with polycystic ovarian syndrome should be treated with metformin?","volume":"17","author":"Nestler","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diab. Care"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus","volume":"83","author":"Holte","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2000.01123.x","article-title":"The prevalence of polycystic ovaries in women with a history of gestational diabetes","volume":"53","author":"Kousta","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0029-7844(98)00133-1","article-title":"Polycystic ovaries in women with gestational diabetes","volume":"2","author":"Anttila","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jcem.82.2.3727","article-title":"The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome","volume":"82","author":"Fulghesu","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humrep\/13.3.567","article-title":"The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome","volume":"13","author":"Dale","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0015-0282(16)44411-0","article-title":"Relationship of weight to successful induction of ovulation with clomiphene citrate","volume":"32","author":"Shepard","year":"1979","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0015-0282(16)46034-6","article-title":"Clinical and laboratory predictors of clomiphene response","volume":"37","author":"Lobo","year":"1982","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB39","first-page":"23","article-title":"Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citratem","volume":"44","author":"Murakawa","year":"1999","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0021-9681(82)90120-5","article-title":"Effects of obesity on sex steroid metabolism","volume":"35","author":"Bates","year":"1982","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB43","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/213203a0","article-title":"Specific inhibition of gluconeogenesis by biguanides","volume":"213","author":"Meyer","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB45","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/0006-2952(88)90617-X","article-title":"Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin","volume":"37","author":"Wollen","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/BF00873219","article-title":"Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes","volume":"29","author":"Jacobs","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/diab.40.7.850","article-title":"Association of metformin\u2019s effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes","volume":"40","author":"Matthaei","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB48","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0306-3623(93)90411-P","article-title":"Metformin: an update","volume":"24","author":"Bailey","year":"1993","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB49","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2337\/diacare.20.12.1863","article-title":"Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue","volume":"20","author":"Abbasi","year":"1997","journal-title":"Diab. Care"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil. Steril."},{"issue":"276","key":"10.1016\/j.ejogrb.2003.11.027_BIB51","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta-hydroxysteroid dehydrogenase","volume":"18","author":"Arlt","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB52","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB54","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB55","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"suppl. 2","key":"10.1016\/j.ejogrb.2003.11.027_BIB57","first-page":"A81","article-title":"Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone","volume":"50","author":"Buchanan","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB58","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000053002","article-title":"Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome","volume":"53","author":"Vrbikova","year":"2002","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB60","first-page":"212","article-title":"Biochemical and body weight changes with metformin in polycystic ovary syndrome","volume":"28","author":"Baysal","year":"2001","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)","volume":"29","author":"Glueck","year":"2001","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB64","first-page":"3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ibanez","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB67","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/diacare.16.10.1387","article-title":"Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women","volume":"16","author":"Giugliano","year":"1993","journal-title":"Diab. Care"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB68","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0020-7292(01)00470-2","article-title":"Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin","volume":"75","author":"Parsanezhad","year":"2001","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB70","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"Ng","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB74","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB75","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/16.6.1086","article-title":"The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome","volume":"16","author":"Fedorcsak","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB76","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB78","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB81","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0015-0282(02)04800-8","article-title":"Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome","volume":"79","author":"Haas","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB82","first-page":"785","article-title":"Metformin for the treatment of polycystic ovary syndrome","volume":"101","author":"Barbiri","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(03)13493-9","article-title":"Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome","volume":"361","author":"Harborne","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB84","unstructured":"American College of Obstetricians and Gynecologists. Polycystic ovary syndrome. Practice Bulletin Number 41; December 2002."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB85","unstructured":"Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003;3:CD003053."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB86","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humrep\/17.4.853","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin?","volume":"17","author":"Homburg","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB87","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/humrep\/17.9.2230","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin?","volume":"17","author":"Seli","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.11.027_BIB88","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/humrep\/17.12.3016","article-title":"Should patients with polycystic ovary syndrome be treated with metformin?","volume":"17","author":"Stadtmauer","year":"2002","journal-title":"Hum. Reprod."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:11:02Z","timestamp":1759554662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0301211504000612"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.11.027","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance and metformin in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}